1. Home
  2. NUVB vs WTTR Comparison

NUVB vs WTTR Comparison

Compare NUVB & WTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • WTTR
  • Stock Information
  • Founded
  • NUVB 2018
  • WTTR 2016
  • Country
  • NUVB United States
  • WTTR United States
  • Employees
  • NUVB N/A
  • WTTR N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • WTTR Oilfield Services/Equipment
  • Sector
  • NUVB Health Care
  • WTTR Energy
  • Exchange
  • NUVB Nasdaq
  • WTTR Nasdaq
  • Market Cap
  • NUVB 837.0M
  • WTTR 922.1M
  • IPO Year
  • NUVB N/A
  • WTTR 2017
  • Fundamental
  • Price
  • NUVB $2.75
  • WTTR $7.92
  • Analyst Decision
  • NUVB Strong Buy
  • WTTR Strong Buy
  • Analyst Count
  • NUVB 6
  • WTTR 4
  • Target Price
  • NUVB $8.00
  • WTTR $14.88
  • AVG Volume (30 Days)
  • NUVB 4.6M
  • WTTR 1.0M
  • Earning Date
  • NUVB 08-07-2025
  • WTTR 08-05-2025
  • Dividend Yield
  • NUVB N/A
  • WTTR 3.54%
  • EPS Growth
  • NUVB N/A
  • WTTR N/A
  • EPS
  • NUVB N/A
  • WTTR 0.32
  • Revenue
  • NUVB $14,355,000.00
  • WTTR $1,458,995,000.00
  • Revenue This Year
  • NUVB $98.78
  • WTTR $2.96
  • Revenue Next Year
  • NUVB $489.71
  • WTTR $4.82
  • P/E Ratio
  • NUVB N/A
  • WTTR $24.54
  • Revenue Growth
  • NUVB 900.35
  • WTTR N/A
  • 52 Week Low
  • NUVB $1.54
  • WTTR $7.20
  • 52 Week High
  • NUVB $3.46
  • WTTR $15.14
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 67.35
  • WTTR 29.01
  • Support Level
  • NUVB $2.18
  • WTTR $8.13
  • Resistance Level
  • NUVB $2.55
  • WTTR $9.21
  • Average True Range (ATR)
  • NUVB 0.18
  • WTTR 0.38
  • MACD
  • NUVB 0.03
  • WTTR -0.14
  • Stochastic Oscillator
  • NUVB 82.48
  • WTTR 0.77

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

About WTTR Select Water Solutions Inc.

Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.

Share on Social Networks: